HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions

HPV (Human papillomavirus) affects 600,000 people worldwide each year. Almost all cervical cancers are associated with a past HPV infection. In particular, the positivity to the high-risk type HPV16 is detected in most of the invasive cervical cancers. FDA has approved prophylactic vaccines that pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Kun, Yuzhakov, Olga, Behloul, Nouredine, Wang, Dehua, Bhagat, Lakshmi, Chu, Dafeng, Zhang, Xinyue, Cheng, Xinwei, Fan, Lusheng, Huang, Xinyu, Mirabella, Teodelinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368880/
https://www.ncbi.nlm.nih.gov/pubmed/37503351
http://dx.doi.org/10.3389/fimmu.2023.1213285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368880/
https://www.ncbi.nlm.nih.gov/pubmed/37503351
http://dx.doi.org/10.3389/fimmu.2023.1213285

Ejemplares similares